The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 06, 2019

Filed:

Jun. 03, 2016
Applicant:

Pellepharm, Inc., Orinda, CA (US);

Inventors:

Marc Barry Brown, Watford, GB;

Cameron Robert Stevenson, Guildford, GB;

Charles Rodney Greenaway Evans, Worthing, GB;

Assignee:

PellePharm, Inc., Orinda, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/70 (2006.01); A61K 47/02 (2006.01); A61K 47/08 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/22 (2006.01); A61K 31/496 (2006.01); A61K 31/4355 (2006.01);
U.S. Cl.
CPC ...
A61K 31/496 (2013.01); A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 9/7084 (2013.01); A61K 31/4355 (2013.01); A61K 47/02 (2013.01); A61K 47/08 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/22 (2013.01);
Abstract

Compositions for topical administration of a hedgehog inhibitor compound are described. In one embodiment, the hedgehog inhibitor compound is patidegib and the topical composition comprises the compound in a solvent system of a monohydric primary alcohol and a polyol in a w/w ratio of between about 0.9-1.8. In another embodiment, the hedgehog inhibitor is itraconazole and the topical composition comprises the compound in a solvent system comprising a monohydric primary alcohol and an optionally lower alkyl end-capped oligomeric alkylene glycol in a w/w ratio of between about 0.8 and 2.6 and a fused bicyclic ether. Method of using the compositions are also described, where in one embodiment, the compositions are topically applied for treating or preventing basal cell carcinoma.


Find Patent Forward Citations

Loading…